Clinical Trials for Stage IIA Pancreatic Cancer AJCC v8

Find clinical trials for stage iia pancreatic cancer ajcc v8. Discover research opportunities and treatment options in your area.

5 Active Trials Found

Showing 5 trials on this page

Page 1 of 1

Sonoporation and Chemotherapy for the Treatment of Pancreatic Cancer

NCT ID: NCT04821284

This clinical trial is studying a new treatment approach for pancreatic cancer that combines standard chemotherapy with a technique called sonoporation. Sonoporation uses ultrasound waves and tiny ...

Recruiting

Phase: PHASE1 Type: interventional Locations: Bergen, , Norway, Philadelphia, Pennsylvania, United States

Investigational Scan (68Ga-FAPI-46 PET/CT) for Imaging of Cancer-Associated Fibroblasts for Localized Pancreatic Ductal Adenocarcinoma

NCT ID: NCT05518903

This clinical trial is studying a new type of imaging test called the 68Ga-FAPI-46 PET/CT scan to see if it can help doctors find specific cells related to pancreatic cancer, known as cancer-associ...

Recruiting

Phase: PHASE2 Type: interventional Locations: Rochester, Minnesota, United States

Lenvatinib and Pembrolizumab Maintenance Therapy for the Treatment of Patients of Advanced Unresectable Pancreatic Cancer

NCT ID: NCT04887805

This clinical trial is studying a combination of two medications, lenvatinib and pembrolizumab, to see if they can help patients with advanced pancreatic cancer that cannot be surgically removed. L...

Recruiting

Phase: PHASE2 Type: interventional Locations: Duarte, California, United States

Calaspargase Pegol-Mnkl and Cobimetinib for the Treatment of Locally Advanced or Metastatic Pancreatic Cancer

NCT ID: NCT05034627

This clinical trial is studying a new treatment approach for patients with locally advanced or metastatic pancreatic cancer, which means the cancer has either spread to nearby tissues or to other p...

Recruiting

Phase: PHASE1 Type: interventional Locations: Portland, Oregon, United States

A Study to Determine if the Drug, Pyrvinium Pamoate, is Safe and Tolerable in Patients With Pancreatic Cancer

NCT ID: NCT05055323

This clinical trial is studying a medication called pyrvinium pamoate to see if it is safe and tolerable for patients with pancreatic cancer that can be surgically removed. The goal is to find out ...

Recruiting

Phase: PHASE1 Type: interventional Locations: Philadelphia, Pennsylvania, United States

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions